PHARYNGOLARYNGEAL ABSCESS

PHARYNGOLARYNGEAL ABSCESS was reported 23 times

PHARYNGOLARYNGEAL ABSCESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Neuraminidase Inhibitor [EPC] 1 0.0004
1 RNA Synthetase Inhibitor Antibacterial [EPC] 2 0.0001
2 Human Immunoglobulin G [EPC] 3 0.0001
3 Antimalarial [EPC] 1 0.0001
4 Antiprotozoal [EPC] 1 0.0001
5 Progesterone [EPC] 2 0.0001
6 Provitamin D2 Compound [EPC] 2 0.0001
7 Catecholamine [EPC] 3 0.0000
8 Interleukin-17A Antagonist [EPC] 1 0.0000
9 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
10 Amide Local Anesthetic [EPC] 2 0.0000
11 Protease Inhibitor [EPC] 1 0.0000
12 Purine Antimetabolite [EPC] 2 0.0000
13 Antiarrhythmic [EPC] 2 0.0000
14 Parathyroid Hormone Analog [EPC] 2 0.0000
15 Complement Inhibitor [EPC] 1 0.0000
16 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
17 Nucleoside Analog Antiviral [EPC] 1 0.0000
18 Integrin Receptor Antagonist [EPC] 1 0.0000
19 Estrogen [EPC] 2 0.0000
20 Aminosalicylate [EPC] 1 0.0000
21 Interleukin-12 Antagonist [EPC] 1 0.0000
22 Interleukin-23 Antagonist [EPC] 1 0.0000
23 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
24 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
25 Vitamin C [EPC] 2 0.0000
26 Alkylating Drug [EPC] 1 0.0000
27 Corticosteroid [EPC] 5 0.0000
28 Proton Pump Inhibitor [EPC] 2 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
32 Kinase Inhibitor [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000